By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics. Its proprietary product candidates are X358, X213, X129, and Gevokizumab. The business operations of the company function through the United States, Europe, and the Asia Pacific. XOMA's primary source of revenue is from license and collaboration arrangements, contract services, and royalties and the majority of the revenue is generated from the United States.

Contact Information

Website: www.xoma.com
Email: InvestorRelations@xoma.com
Main Phone: +1 510 204-7200
Address: 2200 Powell Street
Address 2: Suite 310
State: CA
City / Town: Emeryville
Country: US
Postal Code: 94608

Issuer Information

Exchange: NSD
CEO: James R. Neal
Employees: 10
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A